Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
A novel lotion formulation of fluticasone propionate 0.05% has recently become available. Two large, randomized, placebo-controlled, double-blind studies involving 438 subjects demonstrated its efficacy and safety when applied once daily in the treatment of atopic dermatitis in subjects from 3 months to 87 years of age. The studies were limited to 4 weeks duration of use of fluticasone lotion and did not assess longer term efficacy or side effects.
Children's Hospital and Health Center-San Diego, University of California, San Diego, California, USA.
Lawrence F
LF
Eichenfield
B H
BH
Miller
D000287:Administration, Topical; D000293:Adolescent; D000730:Androstadienes / Q000008:administration & dosage* / Q000009:adverse effects; D018926:Anti-Allergic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D000068298:Fluticasone; D006801:Humans; D007223:Infant; D009824:Ointments
D000730:Androstadienes; D018926:Anti-Allergic Agents; D003879:Dermatologic Agents; D009824:Ointments; D000068298:Fluticasone